Toronto - Free Realtime Quote CAD
Fennec Pharmaceuticals Inc. (FRX.TO)
9.04
0.00
(0.00%)
As of May 8 at 12:11:23 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
26,980
26,980
-17,143
-18,058
-14,222
Financing Cash Flow
-13,615
-13,615
6,638
20,732
4,978
End Cash Position
26,634
26,634
13,269
23,774
21,100
Issuance of Capital Stock
--
--
--
--
0
Issuance of Debt
--
--
4,997
24,935
5,000
Repayment of Debt
-13,000
-13,000
0
-5,000
0
Free Cash Flow
26,980
26,980
-17,143
-18,058
-14,222
12/31/2021 - 6/12/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ZHCLF Zenith Capital Corp.
0.0001
0.00%
MBIO.CN MindBio Therapeutics Corp.
0.0050
0.00%
EPRX.TO Eupraxia Pharmaceuticals Inc.
5.44
+2.26%
MIR.V MedMira Inc.
0.0850
0.00%
BCT.TO BriaCell Therapeutics Corp.
4.5500
+3.41%
APS.TO Aptose Biosciences Inc.
2.2300
+0.45%
RVX.TO Resverlogix Corp.
0.0450
0.00%
NGEN.V NervGen Pharma Corp.
3.5500
-1.11%
ZBIO Zenas BioPharma, Inc.
9.33
+0.43%
SVA.TO Sernova Biotherapeutics Inc
0.1950
-2.50%